Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-08-01
1998-03-24
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 546 90, 546153, 546154, 546156, 546157, C07D215227, C07D21520, A61K 3147
Patent
active
057313210
ABSTRACT:
Novel compounds of the formula I ##STR1## in which --Y--Z--, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 have the meanings as stated in the specification, and their salts show endothelin receptor antagonist properties.
REFERENCES:
patent: 5292740 (1994-03-01), Burri et al.
patent: 5371226 (1994-12-01), Mederski et al.
patent: 5514691 (1996-05-01), Chan et al.
patent: 5565472 (1996-10-01), Hamanaka et al.
Fehnel, Edward A., "Friedlander Syntheses with o-Aminoaryl Ketones . . ", J. Heterocyclic. Chem., vol. 4, No. 4, 1967, pp. 565-570.
Derwent Abstract of JP 6 340 658, 1994.
Matsumori et al., Chemical Abstracts 79:5234v, 1973.
Christadler Maria
Dorsch Dieter
Mederski Werner
Osswald Mathias
Schmitges Claus J.
Merck Patent Gesellschaft mit beschrankter Haftung
Rao Deepak R.
Shah Mukund J.
LandOfFree
Endothelin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2289184